Mustang Bio Inc. (NASDAQ: MBIO) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT MUSTANG BIO INC.

Mustang Bio Inc. (NASDAQ: MBIO)
Listen to this Section


$3.19
-0.4450 ( -14.61% ) 311.5K

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Market Data


Open $3.19
Previous Close $3.63
Volume 311.5K
Market Cap $4.83M
Day Range $3.11 - $4.00
52 Week Range $3.11 - $74.50
Shares Outstanding 1.31M
Change % -14.61%
Net Change ▼ -0.4450
Insider Ownership 0.00%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2017
Country United States

Insider Ownership Transactions

Total Amount Purchased: -421,736.00

Date Type Amount Purchased Purchaser
2024-06-04 Sale -1248.00 Litchman Manuel MD
2024-06-04 Sale -1396.00 Litchman Manuel MD
2024-01-03 Sale -419092.00 Fortress Biotech, Inc.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
def Proxies and info statements 2 Jan 22, 2025
8-k 8K-related 17 Jan 17, 2025
s-1 Registration statements 126 Jan 15, 2025
8-k 8K-related 13 Jan 10, 2025
pre Proxies and info statements 2 Jan 10, 2025
8-k 8K-related 13 Jan 02, 2025
def Proxies and info statements 5 Dec 06, 2024
424b3 Other 2 Dec 02, 2024
effect Other 1 Nov 27, 2024
corresp Comment letters 1 Nov 25, 2024

Latest News


× Before browsing our site, please accept our cookies policy